Entheon Biomedical
  • CSE:ENBI
  • OTC:ENTBF
  • ABOUT ENTHEON
  • REASONS TO BELIEVE
  • TEAM
  • INVESTORS
    • SHARE STRUCTURE
    • STOCK INFORMATION
    • FINANCIAL STATEMENTS
    • PRESS RELEASES & NEWS
  • CONTACT
Select Page
Psychedelic Finance Spotlight: Timothy Ko | CEO, Entheon Biomedical

Psychedelic Finance Spotlight: Timothy Ko | CEO, Entheon Biomedical

by Entheogen Biomedical | May 14, 2020 | Company News

Full text and insights available on Psychedelic Finance website Timothy’s passion for the Entheogen space is shaped by firsthand knowledge of the shortcomings of the current mental health system and through his exposure to psychedelics which he credits with saving his...

Recent Posts

  • Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific
  • Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial
  • Entheon Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange
  • When Will Psychedelics be Legal in the United States?
  • MPV annonce l’approbation conditionnelle de sa transaction avec Entheon Biomedical Corp. par le CSE

Recent Comments

    Archives

    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • June 2020
    • May 2020
    • April 2020
    • February 2020
    • December 2019
    • November 2019
    • July 2019
    • April 2019
    • December 2018
    • February 2018
    • January 2018

    Categories

    • Company News
    • Industry News
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Entheon Biomedical 2020 © All rights reserved | Website by S3 Communications | Terms & Privacy